Speaker Profile
Vice President Clinical, Oxford Nanopore
Biography
As Head of Oxford Nanopore Diagnostics (OND), Emma supports Oxford Nanopores ambitions for growth in healthcare applications.Until November 2020, Emma was Director for Supplies and Innovation as part of the British governments NHS Test and Trace response to COVID19. Prior to this, Emma was CEO of Four Eyes Insight, Chief Partnership Officer for Beacon Health Options (Northeast USA) and CEO of Beacon in the UK. Emma has also been a Commonwealth Fund Harkness Fellow in Healthcare Policy and Practice and a Senior Associate at the Institute for Strategy and Competitiveness, both at Harvard University. Prior to this, Emma was a practicing clinician in the UKs National Health Service (NHS).
Session Abstract – PMWC 2024 Silicon Valley
Track Chair: Stacey Gabriel, Broad Institute and Steve Turner, PacBio
- New Frontiers in Genomic Analysis & Interpretation (PANEL)
- Robert Sebra, ISMMS - From Potential to Reality: Bringing Nanopore Sequencing to Clinical Practice (PANEL)
Chair: Emma Stanton, Oxford Nanopore Tech - Charles Chiu, UCSF - Population Sequencing at Scale: Impact and Future Path of Genomic Programs (PANEL)
Chair: Stacey Gabriel, Broad Institute
- Heidi Rehm, MGH
- Cindy Lawley, Olink
- John M. Gaziano, Million Veterans Program (MVP) - The Economic Perspective on Genomics (PANEL)
Chair: Paul Spellman, UCLA
- Walter Kowtoniuk, Third Rock Ventures - Building Bridges: Precision Medicine Communities
- Kumar Prashant, Karkinos
